Ethyl 4-(dimethylamino)benzoate

Market Intelligence Report on Ethyl 4-(Dimethylamino)benzoate (2026 July)

I. Price Dynamics (July 1–3, 2026)
| Date | Benchmark Price (CNY/ton) | Price Fluctuation Range (CNY/ton) | Regional Price Spread (CNY/ton) | Key Influencing Factors |
|------------|---------------------------|-------------------------------------|-----------------------------------|------------------------------------------------------|
| 2026-07-01 | 53,000 | 52,800–53,200 | East China–South China: ±800 | Rising dimethylamine raw material costs; logistics cost adjustments |
| 2026-07-02 | 53,000 | 52,900–53,100 | Central China–East China: ±600 | Optimization of payment terms; brand premium volatility |
| 2026-07-03 | 53,200 | 53,000–53,400 | North China–South China: ±1,000 | Increased export orders; regional inventory disparities |

Small-batch retail market:
- Hubei Tianmen supplier: 25 kg/drum, CNY 36–120/kg (including logistics costs)
- Shanghai Kolaman Reagents: 100 g/bottle, CNY 200/bottle (cosmetic-grade, for R&D use)
- Jiangsu Nantong national-standard product: CNY 53,000/ton (bulk procurement negotiable)

II. Market Drivers Analysis
1. Upstream Raw Material Costs
- Dimethylamine (core raw material): Prices fluctuated with natural gas prices; cumulative Q2 2026 increase of 12%, directly pushing up EDB production costs by ~8%.
- Ethyl acetate solvent prices remained stable; however, tightened environmental regulations led to the exit of some small-capacity producers, causing regional supply tightness.

2. Downstream Demand Structure
- UV-Curable Coatings: 65% share; demand rose 18% YoY in H1 2026, driven by 5G base station construction and new-energy vehicle coating applications.
- Pharmaceutical Intermediates: 25% share; steady demand from antihypertensive drugs and antibiotic synthesis, though profit margins compressed under centralized drug procurement policies.
- Agrochemicals: 10% share; herbicide raw material demand seasonally impacted; expected Q3 sequential decline of 15%.

3. Regional Supply-Demand Disparities
- East China Region: Accounts for 45% of national capacity, concentrated among producers such as Nantong Zhonghe and Changzhou Yangguang; however, environmental compliance restrictions reduced operating rates to <80%.
- Central China Region: Hubei Huida added 10,000 tons/year capacity, intensifying regional price competition; South China buyers increasingly sourcing from Central China.
- Export Market: H1 2026 export volume increased 22% YoY, primarily to Southeast Asia (Vietnam, India) and Europe (Germany, Italy); RMB depreciation favorable for exports.

III. Competitive Landscape & Key Players
| Company Name | Capacity (tons/year) | Market Share | Core Strengths | 2026 Developments |
|--------------------------------|----------------------|--------------|---------------------------------------------|--------------------------------------------|
| Hunan Jiuri New Materials | 8,000 | 28% | Integrated photoinitiator production | Expanding Hubei facility; scheduled Q3 commissioning |
| Changzhou Yonghe Fine Chemical | 6,000 | 21% | Comprehensive pharmaceutical-grade certifications | Signed long-term supply agreement with Merck |
| Hubei Huida Technology | 5,000 | 18% | Cost advantage (proximity to raw materials in Central China) | Launched dedicated export route to India |
| Nantong Zhonghe Chemical | 4,500 | 16% | Extensive regional distribution network in East China | Launched low-VOC environmental variant |

IV. Price Forecast & Risk Alerts
1. Short-Term Forecast (July–September 2026)
- Price Range: CNY 52,500–54,000/ton (benchmark); regional spread widening to ±CNY 1,200/ton.
- Driving Logic:
Sustained high dimethylamine prices providing strong cost support;
Ongoing environmental restrictions in East China; Central China supply filling gap;
Concentrated export order deliveries causing short-term supply tightness.

2. Long-Term Trend (2026–2027)
- Capacity Expansion: Hunan Jiuri’s Hubei facility (8,000 tons/year) and Zhejiang Youchuang (5,000 tons/year) scheduled for Q4 2026 commissioning; 2027 capacity utilization projected at 95%, exerting downward pricing pressure.
- Technological Substitution: Emerging photoinitiators (e.g., acyl phosphine oxides) gaining market share; EDB demand growth slowing to 6–8% per annum.
- Regulatory Impact: Tightening EU REACH regulations increasing compliance costs for exporters.

3. Risk Alerts
- Raw Material Risk: Volatility in natural gas prices; potential dimethylamine supply disruptions due to environmental inspections.
- Demand Risk: Expansion of pharmaceutical centralized procurement; adjustments to export tax rebates for agrochemicals.
- Competitive Risk: Low-price dumping (e.g., Indian imports) threatening domestic market stability.

V. Operational Recommendations
1. Procurement Side:
- East China customers advised to shift sourcing to Central China suppliers and lock in orders for July–August to hedge against further price hikes.
- Exporters should pre-stock inventory ahead of Q4 shipping peak to mitigate freight capacity constraints.
2. Production Side:
- Optimize processes to reduce unit consumption (target: 5% reduction in dimethylamine usage).
- Develop high-value-added products (e.g., pharmaceutical-grade EDB), aiming for 10–15% gross margin improvement.
3. Investment Side:
- Monitor integration opportunities along the photoinitiator value chain (e.g., Jiuri New Materials’ M&A precedents).
- Exercise caution when evaluating new capacity projects to avoid redundant investment and overcapacity.